XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.2.u1
EQUITY METHOD INVESTMENTS (Details Narrative)
3 Months Ended 12 Months Ended
Mar. 31, 2024
USD ($)
Mar. 31, 2024
CAD ($)
Mar. 31, 2024
EUR (€)
Mar. 31, 2023
USD ($)
Dec. 31, 2023
CAD ($)
Dec. 31, 2023
USD ($)
Gain on extinguishment of debt $ 0     $ 1,908,513    
Cosmo Farmacy LP [Member]            
Initial share capital | €     € 150,000      
Initial share capital increased | €     500,000      
Pharmacy license value | €     € 350,000      
Maturity period of license 30 years 30 years 30 years      
Ownership equity 70.00%          
Cash contributed to limited partner | €     € 150,000      
Equity ownership remaining 30.00%          
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member]            
Upfront cash received   $ 2,000,000     $ 2,000,000  
Fair value of settlement account $ 1,554,590          
Gain on extinguishment of debt 1,554,590          
Cash received upon gross sales   2,750,000     2,750,000  
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member] | Gross Sales One [Member]            
Cash received upon gross sales   2,750,000        
Gross sales   13,000,000        
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member] | Gross Sales [Member]            
Cash received upon gross sales         $ 2,750,000  
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member] | Gross Sales [Member]            
Gross sales   $ 6,500,000        
Share Exchange Agreement [Member] | ICC [Member]            
Investement $ 161,865         $ 165,930